|

German Spondyloarthritis Inception Cohort

RECRUITINGSponsored by Charite University, Berlin, Germany
Actively Recruiting
SponsorCharite University, Berlin, Germany
Started2000-07
Est. completion2030-07
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT01277419

Summary

The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA including ankylosing spondylitis (AS, also known as radiographic axial spondyloarthritis) and non-radiographic axial SpA. The objectives of GESPIC are to learn about the course of SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs). GESPIC has been recently expanded to recruit patients with other forms of SpA / conditions associated with SpA: acute anterior uveitis, Crohn's disease as well as with psoriasis / axial psoriatic arthritis.

Eligibility

Healthy volunteers accepted
Main inclusion Criteria:

* Patients with definite diagnosis of axial spondyloarthritis or juvenile spondyloarthritis.
* Patients with definite diagnosis of Crohn's disease.
* Patients with definite diagnosis of acute anterior uveitis.
* Patients with definite diagnosis of psoriatic arthritis with axial involvement.

Conditions7

Acute Anterior Uveitis (AAU)Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)ArthritisAxial Psoriatic Arthritis (axPsA)Crohn Disease (CD)Non-radiographic Axial Spondyloarthritis (Nr-axSpA)Ulcerative Colitis (UC)

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.